Literature DB >> 23146281

Characterization of extensively drug-resistant Mycobacterium tuberculosis in Nepal.

Ajay Poudel1, Bhagwan Maharjan, Chie Nakajima, Yukari Fukushima, Basu D Pandey, Antje Beneke, Yasuhiko Suzuki.   

Abstract

The emergence of extensively drug-resistant tuberculosis (XDR-TB) has raised public health concern for global control of TB. Although molecular characterization of drug resistance-associated mutations in multidrug-resistant isolates in Nepal has been made, mutations in XDR isolates and their genotypes have not been reported previously. In this study, we identified and characterized 13 XDR Mycobacterium tuberculosis isolates from clinical isolates in Nepal. The most prevalent mutations involved in rifampicin, isoniazid, ofloxacin, and kanamycin/capreomycin resistance were Ser531Leu in rpoB gene (92.3%), Ser315Thr in katG gene (92.3%), Asp94Gly in gyrA gene (53.9%) and A1400G in rrs gene (61.5%), respectively. Spoligotyping and multilocus sequence typing revealed that 69% belonged to Beijing family, especially modern types. Further typing with 26-loci variable number of tandem repeats suggested the current spread of XDR M. tuberculosis. Our result highlights the need to reinforce the TB policy in Nepal with regard to control and detection strategies.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23146281     DOI: 10.1016/j.tube.2012.10.007

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  11 in total

1.  Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains.

Authors:  Tomasz Jagielski; Zofia Bakuła; Anna Brzostek; Alina Minias; Radosław Stachowiak; Joanna Kalita; Agnieszka Napiórkowska; Ewa Augustynowicz-Kopeć; Anna Żaczek; Edita Vasiliauskiene; Jacek Bielecki; Jarosław Dziadek
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis.

Authors:  Christine Bernard; Nicolas Veziris; Florence Brossier; Wladimir Sougakoff; Vincent Jarlier; Jérôme Robert; Alexandra Aubry
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

3.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

4.  Drug-resistant Mycobacterium tuberculosis and its genotypes isolated from an outbreak in western Thailand.

Authors:  Janisara Rudeeaneksin; Benjawan Phetsuksiri; Chie Nakajima; Supranee Bunchoo; Krairerk Suthum; Nattakan Tipkrua; Yukari Fukushima; Yasuhiko Suzuki
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-08-02       Impact factor: 2.184

5.  Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates.

Authors:  Fei Liu; Yongfei Hu; Qi Wang; Hong Min Li; George F Gao; Cui Hua Liu; Baoli Zhu
Journal:  BMC Genomics       Date:  2014-06-13       Impact factor: 3.969

Review 6.  Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.

Authors:  Elisea Avalos; Donald Catanzaro; Antonino Catanzaro; Theodore Ganiats; Stephanie Brodine; John Alcaraz; Timothy Rodwell
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

7.  Comprehensive Analysis and Comparison on the Codon Usage Pattern of Whole Mycobacterium tuberculosis Coding Genome from Different Area.

Authors:  Li Gun; Ren Yumiao; Pan Haixian; Zhang Liang
Journal:  Biomed Res Int       Date:  2018-05-08       Impact factor: 3.411

8.  Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman M Mokaddas
Journal:  Eur J Med Res       Date:  2019-12-05       Impact factor: 2.175

9.  Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China.

Authors:  Qi Wang; Susanna K P Lau; Fei Liu; Yanlin Zhao; Hong Min Li; Bing Xi Li; Yong Liang Hu; Patrick C Y Woo; Cui Hua Liu
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011.

Authors:  Hoa Binh Nguyen; Nhung Viet Nguyen; Huong Thi Giang Tran; Hai Viet Nguyen; Quyen Thi Tu Bui
Journal:  Western Pac Surveill Response J       Date:  2016-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.